|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1996-10-24
|
|
pubmed:abstractText |
Despite improvement in the response rate and protraction of the progression-free period of urothelial cancer produced by chemotherapy, severe bone marrow suppression often results in delays in the initiation of treatment cycles and/or decreases in drug dosages. Reduction of leukopenia during chemotherapy has been demonstrated by the combined administration of granulocyte colony-stimulating factor (G-CSF) in various malignancies.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0919-8172
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
2
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
316-21
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8749950-Adolescent,
pubmed-meshheading:8749950-Adult,
pubmed-meshheading:8749950-Aged,
pubmed-meshheading:8749950-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8749950-Carcinoma, Transitional Cell,
pubmed-meshheading:8749950-Cisplatin,
pubmed-meshheading:8749950-Cyclophosphamide,
pubmed-meshheading:8749950-Doxorubicin,
pubmed-meshheading:8749950-Drug Administration Schedule,
pubmed-meshheading:8749950-Female,
pubmed-meshheading:8749950-Granulocyte Colony-Stimulating Factor,
pubmed-meshheading:8749950-Humans,
pubmed-meshheading:8749950-Male,
pubmed-meshheading:8749950-Middle Aged,
pubmed-meshheading:8749950-Pilot Projects,
pubmed-meshheading:8749950-Prospective Studies,
pubmed-meshheading:8749950-Recombinant Proteins,
pubmed-meshheading:8749950-Urinary Bladder Neoplasms
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
Shorter interval between cycles of cyclophosphamide, doxorubicin, cisplatin using recombinant human granulocyte colony-stimulating factor for urothelial cancer--phase I/II study.
|
|
pubmed:affiliation |
Department of Urology, Kyoto University, Japan.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Clinical Trial, Phase II,
Clinical Trial, Phase I
|
